Literature DB >> 7808215

The influence of education and experience on ethical attitudes in neonatal intensive care.

J L Beausoleil1, E L Zalneraitis, D I Gregorio, J M Healey.   

Abstract

A cross-sectional survey of medical students, pediatrics residents, and neonatologists attempted to identify the combined influence of education and experience on ethical attitudes regarding the management of infants weighing less than 750 g at birth. Of the 120 people surveyed, 94 (78%) returned usable surveys. All groups rated quality of life the most important criterion in treatment decisions. Conversely, cost was rated least important by each group. In addition, cost was rated relatively more important by the clinical medical students than by the preclinical students, residents, or neonatologists. The neonatologist was rated the most important decision maker by the neonatologists and the residents. The parents were rated most important by both groups of students. Severe mental retardation was regarded as an unacceptable quality of life by 82% of the neonatologists, 63% of the residents, 61% of the clinical students, and 48% of the preclinical students. Severe cerebral palsy was considered an unacceptable quality of life by 73% of the neonatologists, 63% of the residents, 50% of the clinical students, and only 32% of the preclinical students. Finally, the anticipated long-term outcome of extremely-low-birth-weight infants was viewed more positively by the neonatologists than by the other groups surveyed.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; University of Connecticut School of Medicine

Mesh:

Year:  1994        PMID: 7808215     DOI: 10.1177/0272989X9401400411

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  1 in total

1.  Do medical house officers value the health of veterans differently from the health of non-veterans?

Authors:  Michael S Yi; Sara Luckhaupt; Joseph M Mrus; Joel Tsevat
Journal:  Health Qual Life Outcomes       Date:  2004-04-07       Impact factor: 3.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.